Figure 3.
Figure 3. A: Overall survival of peripheral T-cell lymphoma, unspecified (PTCLUS) according to the International Prognostic Index; B: Overall survival of PTCLUS according to proposed new prognostic index (age > 60, performance status > 2, elevated LDH, bone marrow involvement). . / Low risk: 0, 1, 5 y OS 59%; low-intermediate risk: 2, 5 y OS 46%; high-intermediate risk: 3, 5 y OS 40%; high-risk: 18%; P < .0001. Group 1: 0 factors, 5 y OS 62%; group 2: 1 factor, 5 y OS 53%; group 3: 2 factors, 5 y OS 33%; group 4: 3 or 4 factors, 5 y OS 18%; P < .0001. / Abbreviations: LDH, lactate dehydrogenase. / Originally published in Blood. Reprinted from Gallamini A, Stelitano C, Calvi R, et al8 with permission from the American Society of Hematology.

A: Overall survival of peripheral T-cell lymphoma, unspecified (PTCLUS) according to the International Prognostic Index; B: Overall survival of PTCLUS according to proposed new prognostic index (age > 60, performance status > 2, elevated LDH, bone marrow involvement).

Low risk: 0, 1, 5 y OS 59%; low-intermediate risk: 2, 5 y OS 46%; high-intermediate risk: 3, 5 y OS 40%; high-risk: 18%; P < .0001. Group 1: 0 factors, 5 y OS 62%; group 2: 1 factor, 5 y OS 53%; group 3: 2 factors, 5 y OS 33%; group 4: 3 or 4 factors, 5 y OS 18%; P < .0001.

Abbreviations: LDH, lactate dehydrogenase.

Originally published in Blood. Reprinted from Gallamini A, Stelitano C, Calvi R, et al8 with permission from the American Society of Hematology.

Close Modal

or Create an Account

Close Modal
Close Modal